1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Placebo - 50 mg: new trials by email Literature Review of Placebo - 50 mg trials Research Report on Placebo - 50 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata Ritlecitinib 100 mg, Ritlecitinib 50 mg, Placebo - 100 mg - Alopecia Areata | Phase 3 | Recruiting | Pfizer | 674 | 2025-04-01 | 2026-10-20 |
Alopecia (1) · Alopecia Areata (1) · Alopecia universalis (1) · Hair Diseases (1)
Pfizer (1)
Canada (1) · China (1) · Czechia (1) · Japan (1) · Poland (1) · Puerto Rico (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)